Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
Adenosine (endogenous nucleoside)
Indicated for? IV Bolus Dosage? |
PSVT or Narrow Complex Tachycardia
6mg - 1st dose 12 mg - 2nd dose 12 mg - 3rd dose (1-2 min intervals between) |
|
Amiodarone (antiarrhythmic)
Indicated for? IV Bolus Dosage? Infusion Dosing? |
V-Fib/Pulseless V-Tach
300 mg - 1st dose 150 mg - 2nd dose Infusion dosing: Loading: 150 mg over 10 minutes, then 360 mg IV over 6 hours 540 mg IV over 18 hours |
|
Aspirin (NSAID)
Indicated for? PO dose? Suppository Dose? |
Chest Pain/ACS
PO Dose: 160-325 mg Suppository dose: 300 mg |
|
Atropine (parasympathetic blocker)
Indicated for? IV Bolus Dosage? |
Bradycardia
0.5 mg q 3-5 min as needed PEA, Asystole 1 mg q 3-5 min |
|
Atropine special considerations
|
Only used in bradycardias for *symptomatic* patients. Only used in PEA if rate is *slow*. The maximum dosage is 3 mg. Doses of Atropine < .5 mg may result in paradoxical slowing of the heart. NOT indicated in 2nd degree type I or third degree heart block.
|
|
Adenosine considerations
|
Doses are followed by a saline flush. Two subsequent doses of 12 mg each may be administered at 1 - 2 min intervals. Use the port closest to cannulation. The AHA recommends that the dose be cut by half if administering through a central line, or in the presence of Dipyridamole or Carbamazepine. Larger doses are required in the presence of caffeine or Theophylline.
|
|
Amiodarone considerations
|
Cumulative doses > 2.2 g/24 hours are associated with significant hypotension. Do not administer with other drugs that prolong QT interval (ie, Procainamide). Terminal elimination is extremely long - half life lasts up to 40 days.
|
|
Digoxin (cardiac glycoside antiarrhythmic)
Indicated for? IV Bolus Dosage? |
A-Fib/ A-Flutter
10 - 15 mics/kg lean body weight |
|
Digoxin considerations
|
Reduce Digoxin dose by 50% when initiating Amiodarone due to drug interaction. Toxicity may cause serious arrhythmias.
|
|
Diltiazem (calcium channel blocker)
Indicated for? IV Bolus Dosage? |
A-Fib/A-Flutter
15-20 mg over 2 minutes |
|
Diltiazem considerations
|
Do not use in wide-QRS tachycardias of uncertain origin. May cause hypotension.
|
|
Dopamine (catecholamine)
Indicated for? IV dosage? |
Symptomatic Bradycardia, Hypotension
1-5 mic/kg/min - renal perfusion 5-15 mic/kg/min - cardiac dose 10 - 20 mic/kg/min - vasopressor dose |
|
Dopamine considerations
|
Titrate to patient response. Correct hypovolemia with volume replacement BEFORE initiating Dopamine. May cause tachyarrhythmias. Do not mix with Sodium Bicarbonate.
|
|
Epinephrine (catecholamine)
Indicated for? IV dosage? Infusion dosage? |
V-Fib/Pulseless V-Tach, PEA, Asystole, Symptomatic Bradycardia
1 mg every 3-5 minutes Infusion dosage 1 mg in 500mL of D5W or NaCl at 1 mic/min titrated to effect |
|
Epinephrine considerations
|
First line drug in all pulseless rhythms. Bolus given in 10mL of a 1:10,000 solution. May cause myocardial ischemia, angina, and increased myocardial oxygen demand. ET route is discouraged, but if used 2-2.5 mg diluted in 10 mL NaCl.
|
|
Lidocaine (antiarrhythmic)
Indicated for? IV dosage? Infusion dosage? |
V-Fib/Pulseless V-Tach, Stable V-Tach
1-1.5 mg/kg Infusion dosage: 1-4 mg/min (30-50 mic/kg/min) |
|
Lidocaine considerations
|
May repeat at 0.5-0.75 mg/kg every 5-10 minutes to maximum dose 3mg/kg. Prophylactic use in AMI is contraindicated. Use with caution in presence of impaired liver. Discontinue infusion if signs of toxicity develop.
|
|
Magnesium sulfate (electrolyte)
Indicated for? IV dosage? |
Cardiac arrest if torsades or Hypomagnesemia
1-2g in 10 mL D5W over 20 minutes |
|
Magnesium sulfate considerations
|
occasional fall in blood pressure with rapid administration. Use with caution in renal patients.
|
|
Morphine sulfate (opiate analgesic)
Indicated for? IV dosage? |
Chest pain
Pulmonary edema 2-4 mg every 5-30 minutes |
|
Naloxone (opiate antagonist)
Indicated for? IV dosage? |
Narcotic overdose
0.4-2mg |
|
Naloxone considerations
|
If needed, can administer up to 10mg in 10 minutes. Monitor for recurrent respiratory depression. May cause opiate withdrawal. ET route discouraged, but can be used if IV/IO access not available.
|
|
Nitroglycerine (vasodilator)
Indicated for? IV dosage? |
Chest pain/ACS
12.5-25 mics |
|
Nitroglycerine considerations
|
Most commonly given sublingually as a tablet or spray. The dose is 0.3-0.4 mg. Repeat up to 3 doses at 5 minute intervals. Hypotension or bradycardia may occur. Do not use with Viagra and similar drugs.
|
|
Nitroprusside (vasodilator)
Indicated for? IV dosage? |
Hypertensive crisis
0.1 mic/kg/min, titrate upward to effect |
|
nitroprusside considerations
|
May cause hypotension. Use with catution with Viagra and similar drugs. Light-sensitive--bag and tubing must be covered with opaque material.
|
|
Procainamide (antiarrhythmic)
Indicated for? IV dosage? Infusion dosage? |
Wide variety of arrhythmias
IV drip dosage - 20mg/min Infusion dosage: 1-4 mg/min |
|
Procainimide considerations
|
Maximum dosage is 17mg/kg. In presence of cardiac or renal dysfunction, reduce max dose to 12mg/kg. Can cause arrhythmias in presence of AMI, hypokalemia, or hypomagnesemia. Use with caution with other drugs that prolong the QT interval such as Amiodarone.
|
|
Sodium Bicarbonate (buffer)
Indicated for? IV dosage? |
Acidosis, hyperkalemia
1 mEq/kg |
|
Sodium bicarbonate considerations
|
Not recommended for routine use in cardiac arrest patients. If available, use arterial blood gas analysis to guide bicarbonate therapy.
|
|
Vasopressin (hormone)
Indicated for? IV dosage? |
V-fib/V-Tach
PEA, Asystole 10 U IV/IO |
|
Vasopressin considerations
|
Only given one time. May cause cardiac ischemia and angina. May replace first or second dose of Epi. Not recommended for responsive patients with coronary artery disease.
|
|
Verapamil (calcium channel blocker)
Indicated for? IV dosage? |
A-Fib/A-Flutter
PSVT 2.5-5 mg over 2-5 minutes |
|
Verapamil considerations
|
Alternative drug after Adenosine to terminate PSVY with adequate blood pressure and preserved LV function. Can cause peripheral vasodilation and hypotension. Use with extreme caution in patients receiving oral beta blockers.
|